A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome (Q44323787)
Jump to navigation
Jump to search
scientific article published in March 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome |
scientific article published in March 2003 |
Statements
1 reference
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome (English)
1 reference
Hagop Kantarjian
1 reference
Stefan Faderl
1 reference
Jorge Cortes
1 reference
Susan O'Brien
1 reference
Francis Giles
1 reference
Guillermo Garcia-Manero
1 reference
Michael Andreeff
1 reference
Michael Keating
1 reference
Maher Albitar
1 reference
Elihu Estey
1 reference
Deborah Thomas
1 reference
Charles Koller
1 reference
1 March 2003
1 reference
1 reference
97
1 reference
5
1 reference
1234-1241
1 reference
Identifiers
1 reference
1 reference